Latest News

FDA approves Teva’s AJOVY injection for preventive treatment of migraine in adults

Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration has approved AJOVY injection for the preventive treatment of migraine in adults.

Source link

Related posts

Want Good Sleep for Baby? Food May Be Key


New insights on cellular death mechanisms caused by the loss of neuronal cells and astrocytes


San Francisco campaign to stop e-cigarette measure pushes on


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy